Cost and effects of integrated care: a systematic literature review and meta-analysis.
Cost-effectiveness
Economic evaluation
Integrated care; meta-analysis
Journal
The European journal of health economics : HEPAC : health economics in prevention and care
ISSN: 1618-7601
Titre abrégé: Eur J Health Econ
Pays: Germany
ID NLM: 101134867
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
11
09
2019
accepted:
30
06
2020
pubmed:
8
7
2020
medline:
11
9
2021
entrez:
8
7
2020
Statut:
ppublish
Résumé
Health and care services are becoming increasingly strained and healthcare authorities worldwide are investing in integrated care in the hope of delivering higher-quality services while containing costs. The cost-effectiveness of integrated care, however, remains unclear. This systematic review and meta-analysis aims to appraise current economic evaluations of integrated care and assesses the impact on outcomes and costs. CINAHL, DARE, EMBASE, Medline/PubMed, NHS EED, OECD Library, Scopus, Web of Science, and WHOLIS databases from inception to 31 December 2019 were searched to identify studies assessing the cost-effectiveness of integrated care. Study quality was assessed using an adapted CHEERS checklist and used as weight in a random-effects meta-analysis to estimate mean cost and mean outcomes of integrated care. Selected studies achieved a relatively low average quality score of 65.0% (± 18.7%). Overall meta-analyses from 34 studies showed a significant decrease in costs (0.94; CI 0.90-0.99) and a statistically significant improvement in outcomes (1.06; CI 1.05-1.08) associated with integrated care compared to the control. There is substantial heterogeneity in both costs and outcomes across subgroups. Results were significant in studies lasting over 12 months (12 studies), with both a decrease in cost (0.87; CI 0.80-0.94) and improvement in outcomes (1.15; 95% CI 1.11-1.18) for integrated care interventions; whereas, these associations were not significant in studies with follow-up less than a year. Our findings suggest that integrated care is likely to reduce cost and improve outcome. However, existing evidence varies largely and is of moderate quality. Future economic evaluation should target methodological issues to aid policy decisions with more robust evidence on the cost-effectiveness of integrated care.
Sections du résumé
BACKGROUND
BACKGROUND
Health and care services are becoming increasingly strained and healthcare authorities worldwide are investing in integrated care in the hope of delivering higher-quality services while containing costs. The cost-effectiveness of integrated care, however, remains unclear. This systematic review and meta-analysis aims to appraise current economic evaluations of integrated care and assesses the impact on outcomes and costs.
METHODS
METHODS
CINAHL, DARE, EMBASE, Medline/PubMed, NHS EED, OECD Library, Scopus, Web of Science, and WHOLIS databases from inception to 31 December 2019 were searched to identify studies assessing the cost-effectiveness of integrated care. Study quality was assessed using an adapted CHEERS checklist and used as weight in a random-effects meta-analysis to estimate mean cost and mean outcomes of integrated care.
RESULTS
RESULTS
Selected studies achieved a relatively low average quality score of 65.0% (± 18.7%). Overall meta-analyses from 34 studies showed a significant decrease in costs (0.94; CI 0.90-0.99) and a statistically significant improvement in outcomes (1.06; CI 1.05-1.08) associated with integrated care compared to the control. There is substantial heterogeneity in both costs and outcomes across subgroups. Results were significant in studies lasting over 12 months (12 studies), with both a decrease in cost (0.87; CI 0.80-0.94) and improvement in outcomes (1.15; 95% CI 1.11-1.18) for integrated care interventions; whereas, these associations were not significant in studies with follow-up less than a year.
CONCLUSION
CONCLUSIONS
Our findings suggest that integrated care is likely to reduce cost and improve outcome. However, existing evidence varies largely and is of moderate quality. Future economic evaluation should target methodological issues to aid policy decisions with more robust evidence on the cost-effectiveness of integrated care.
Identifiants
pubmed: 32632820
doi: 10.1007/s10198-020-01217-5
pii: 10.1007/s10198-020-01217-5
pmc: PMC7561551
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1211-1221Références
Med Care. 2004 Dec;42(12):1211-21
pubmed: 15550801
Lancet. 2004 Oct 30-Nov 5;364(9445):1583-94
pubmed: 15519628
Gen Hosp Psychiatry. 2014 Sep-Oct;36(5):453-9
pubmed: 24973911
Value Health. 2016 Mar-Apr;19(2):185-91
pubmed: 27021752
Palliat Med. 2018 Feb;32(2):476-484
pubmed: 28434275
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
J Healthc Qual. 2012 May-Jun;34(3):25-33
pubmed: 22059691
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Int J Integr Care. 2016 Oct 19;16(4):3
pubmed: 28316543
BMJ. 1995 Dec 2;311(7018):1447-8
pubmed: 8520313
Int J Integr Care. 2002;2:e12
pubmed: 16896389
Int J Integr Care. 2003 Oct 07;3:e01
pubmed: 16896423
JAMA Intern Med. 2017 Feb 1;177(2):166-175
pubmed: 28027338
Contemp Clin Trials. 2011 Mar;32(2):288-98
pubmed: 21147265
BMC Health Serv Res. 2007 Aug 17;7:129
pubmed: 17705853
Br J Gen Pract. 2007 Dec;57(545):999
pubmed: 18252086
Int J Integr Care. 2019 Sep 09;19(3):17
pubmed: 31565040
Psychiatr Serv. 2009 Jan;60(1):74-9
pubmed: 19114574
Value Health. 2016 Sep - Oct;19(6):892-902
pubmed: 27712719
J Health Econ. 2017 Mar;52:19-32
pubmed: 28182998
Cost Eff Resour Alloc. 2013 Mar 25;11(1):6
pubmed: 23531194
AIDS Care. 2009 Nov;21(11):1388-94
pubmed: 20024715
Dis Manag. 2006 Feb;9(1):45-55
pubmed: 16466341
PLoS One. 2018 Feb 28;13(2):e0191851
pubmed: 29489820
Popul Health Manag. 2017 Jun;20(3):239-248
pubmed: 27565005
J Clin Psychiatry. 2012 Mar;73(3):e402-8
pubmed: 22490266
J Ment Health Policy Econ. 2009 Mar;12(1):33-46
pubmed: 19346565
Int J Integr Care. 2015 Apr 22;15:e013
pubmed: 26034470
AMIA Annu Symp Proc. 2006;:359-63
pubmed: 17238363
Health Aff (Millwood). 2010 May;29(5):991-7
pubmed: 20439896
Am J Health Promot. 2006 Jul-Aug;20(6):suppl 1-17
pubmed: 16871824
J Neurol Neurosurg Psychiatry. 2002 Sep;73(3):250-5
pubmed: 12185154
Health Serv Res. 2018 Oct;53(5):3471-3494
pubmed: 29573398
Br J Psychiatry. 2018 Aug;213(2):456-463
pubmed: 29761751
Open Heart. 2018 Feb 7;5(1):e000584
pubmed: 29531754
Fam Pract. 2016 Apr;33(2):154-60
pubmed: 26811438
BMJ. 1998 May 16;316(7143):1524-8
pubmed: 9582151
Health Policy Plan. 2017 Nov 1;32(suppl_4):iv6-iv12
pubmed: 29194541
BMJ Open. 2016 Nov 21;6(11):e011952
pubmed: 27872113
BMJ. 2019 Jan 22;364:k4817
pubmed: 30670455
Health Aff (Millwood). 2008 May-Jun;27(3):759-69
pubmed: 18474969
J Adv Nurs. 2009 Aug;65(8):1626-35
pubmed: 19493145
Schizophr Bull. 2016 Jul;42(4):896-906
pubmed: 26834024
Age Ageing. 2016 Jan;45(1):30-41
pubmed: 26764392
Syst Rev. 2014 May 29;3:54
pubmed: 24886533
BMJ Open. 2015 Nov 01;5(10):e007284
pubmed: 26525419
PLoS One. 2018 Jun 11;13(6):e0198772
pubmed: 29889859
AIDS Behav. 2017 Mar;21(3):703-711
pubmed: 27094787
Pharmacoeconomics. 2014 Dec;32(12):1157-70
pubmed: 25069632
J Med Screen. 2018 Jun;25(2):99-109
pubmed: 28530515
BMJ. 2004 Jun 26;328(7455):1561-3
pubmed: 15217878
Int J Integr Care. 2009 Apr 08;9:e10
pubmed: 19513179
J Med Econ. 2019 Sep;22(9):945-952
pubmed: 31190590
Health Aff (Millwood). 2012 Nov;31(11):2379-87
pubmed: 23129667
Int J Chron Obstruct Pulmon Dis. 2019 Mar 14;14:645-657
pubmed: 30936689
JBI Libr Syst Rev. 2009;7(3):80-129
pubmed: 27820426
BMC Med. 2009 Oct 26;7:64
pubmed: 19857246
JAMA. 2001 Oct 10;286(14):1715-23
pubmed: 11594896
Health Econ Rev. 2015 May 27;5:11
pubmed: 26029491
Health Soc Care Community. 2019 Jan;27(1):1-30
pubmed: 29667259
Gac Sanit. 2016 Sep-Oct;30(5):352-8
pubmed: 27372221
Value Health. 2015 Dec;18(8):977-86
pubmed: 26686781
Neuropsychiatr Dis Treat. 2017 Jul 18;13:1881-1893
pubmed: 28765710
BMC Health Serv Res. 2018 May 10;18(1):350
pubmed: 29747651
BMC Pulm Med. 2013 Jul 03;13:40
pubmed: 23819836
BMC Geriatr. 2011 Oct 26;11:67
pubmed: 22029878
Dis Manag. 2005 Apr;8(2):114-34
pubmed: 15815160
J Am Geriatr Soc. 2015 Dec;63(12):2494-2504
pubmed: 26663424
Am J Psychiatry. 2001 Oct;158(10):1638-44
pubmed: 11578996
PLoS One. 2012;7(5):e37444
pubmed: 22655047
J Occup Rehabil. 2014 Sep;24(3):555-62
pubmed: 24085535
J Ment Health Policy Econ. 2009 Dec;12(4):205-13
pubmed: 20195008
Palliat Med. 2016 Mar;30(3):296-302
pubmed: 26603186
Can J Aging. 2010 Mar;29(1):139-61
pubmed: 20202271
Pharmacoepidemiol Drug Saf. 2013 Mar;22(3):263-70
pubmed: 23296590
J Clin Epidemiol. 2004 Sep;57(9):881-8
pubmed: 15504631
BMJ. 2020 Jan 6;368:l6964
pubmed: 31907164
Int J Technol Assess Health Care. 2007 Spring;23(2):184-91
pubmed: 17493304
PLoS One. 2015 May 05;10(5):e0121340
pubmed: 25942421
J Clin Pharm Ther. 2018 Dec;43(6):775-783
pubmed: 29696669
Health Econ Policy Law. 2019 Jan;14(1):119-134
pubmed: 29673412
BMC Health Serv Res. 2012 Oct 23;12:366
pubmed: 23088792